910 results on '"Kimmel, Stephen E."'
Search Results
252. The Influence of Patient Adherence on Anticoagulation Control With Warfarin
253. Reply
254. Comparative Risk of Ischemic Stroke Among Users of Clopidogrel Together With Individual Proton Pump Inhibitors.
255. Factors affecting time to maintenance dose in patients initiating warfarin.
256. Effect of psoriasis severity on hypertension control: a population-based study in the United Kingdom.
257. Comparison of Cool Tip Versus 8-mm Tip Catheter in Achieving Electrical Isolation of Pulmonary Veins for Long-Term Control of Atrial Fibrillation: A Prospective Randomized Pilot Study
258. Effectiveness of a Two-Part Educational Intervention to Improve Hypertension Control: A Cluster-Randomized Trial
259. ORIGINAL RESEARCH—ED PHARMACOTHERAPY: Can Atorvastatin Improve the Response to Sildenafil in Men with Erectile Dysfunction Not Initially Responsive to Sildenafil? Hypothesis and Pilot Trial Results
260. Insulin Sensitizing Pharmacotherapy for Prevention of Myocardial Infarction in Patients With Diabetes Mellitus
261. The Role of Risk Stratification in the Decision to Provide Upstream Versus Selective Glycoprotein IIb/IIIa Inhibitors for Acute Coronary Syndromes
262. Risk of Serious Upper Gastrointestinal Toxicity With Over-the-Counter Nonaspirin Nonsteroidal Anti-inflammatory Drugs
263. Predictors of recall of over‐the‐counter and prescription non‐steroidal anti‐inflammatory drug exposure
264. Potential limitations of electronic database studies of prescription non-aspirin non-steroidal anti-inflammatory drugs (NANSAIDs) and risk of myocardial infarction (MI)
265. The effect of cardiac troponin testing on clinical care in a veterans population
266. Medication Safety in Older Adults: Home-Based Practice Patterns
267. The Effect of Primary Graft Dysfunction on Survival after Lung Transplantation
268. Patients Exposed to Rofecoxib and Celecoxib Have Different Odds of Nonfatal Myocardial Infarction
269. Impact of Primary Graft Failure on Outcomes Following Lung Transplantation
270. Hemodynamics and survival of patients with portopulmonary hypertension
271. Model Selection, Confounder Control, and Marginal Structural Models
272. Class effect of angiotensin-converting enzyme inhibitors on prevention of myocardial infarction
273. Plasma Leptin Levels Are Associated with Coronary Atherosclerosis in Type 2 Diabetes
274. Is Improved Survival a Class Effect of Angiotensin-Converting Enzyme Inhibitors?
275. Comparative cardiac safety of low-dose thioridazine and low-dose haloperidol
276. The effects of nonselective non-aspirin non-steroidal anti-inflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirin
277. 1172-67 Use of administrative databases may lead to incorrect estimates of the effects of nonaspirin nonsteroidal anti-inflammatory drugs on mlyocardial infarction risk
278. Adverse Events After Protamine Administration Following Cardiopulmonary Bypass in Infants and Children
279. Effect of Antidepressants and Their Relative Affinity for the Serotonin Transporter on the Risk of Myocardial Infarction
280. Bleeding risk of platelet glycoprotein IIb/IIIa receptor antagonists in broad-based practice (results from the Society for Cardiac Angiography and Interventions Registry)
281. Limitations of current risk-adjustment models in the era of coronary stenting
282. Angiotensin converting enzyme inhibitor tissue affinity is not associated with different risk of myocardial infarction
283. Rheumatoid arthritis is not associated with myocardial infarction after controlling for other risk factors
284. Enhancement of medication recall using medication pictures and lists in telephone interviews
285. Abstract 11294: Rates of Testing in Syncope Patients in the United States Using a National Database
286. Usefulness of the TIMI risk score in predicting both short- and long-term outcomes in the Veterans Affairs Non–Q-Wave Myocardial Infarction Strategies In-Hospital (VANQWISH) Trial
287. The Incidence of Adverse Events after Intra-Operative Protamine Administration in Infants and Children
288. Risk Factors for Hypotension after Intra-Operative Protamine Administration in Infants and Children
289. Racial differences in the prevalence of cardiac sources of embolism in subjects with unexplained stroke or transient ischemic attack evaluated by transesophageal echocardiography
290. Mortality and Adverse Events After Protamine Administration in Patients Undergoing Cardiopulmonary Bypass
291. Relationship between coronary angioplasty laboratory volume and outcomes after hospital discharge
292. Lower myocardial infarction risk from selective serotonin reuptake inhibitors but not other antidepressants
293. Prediction rule for insignificant coronary artery disease in patients being considered for elective coronary angiography
294. Nonselective nonaspirin nonsteroidal antiinflammatory medications are associated with reduced risk of myocardial infarction
295. Parenteral ketorolac and risk of myocardial infarction
296. Selective Serotonin Reuptake Inhibitors and Myocardial Infarction
297. Risk of acute first myocardial infarction and use of nicotine patches in a general population
298. The effects of contemporary use of coronary stents on in-hospital mortality
299. Trial of a novel prostacyclin analog, UT-15, in patients with severe intermittent claudication
300. Efficacy and safety of catheter ablation in octogenarians
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.